BPI Extra - BioProcess International

BPI Extra

Occasionally, articles are edited in order to shorten the length. Other times, we may not have enough space in the journal to print charts and/or accompanying information.

Here you will find supplemental data, resource listings, and commentary on articles in BPI's regular monthly and special issues.

September 2011

Focus on Validation

Implementation of the ASTM Standard for Manufacturing Systems Verification

Example Documents

Vendor Voice

Localized Surface Plasmon Resonance for Bioprocess Development, Manufacturing, and Validation

A Preprint from LamdaGen

December 2010

Electronic Preprint

Industrial-Scale Biochromatography Columns Address Challenging Purification Needs

Vendor Voice

November 2010

Special Report: Supplemental Material

Protein Conjugates: Facing the Challenges of Their Development and Manufacture

Protein Conjugates

October 2010

Supporting Data

Formulation Effects on Opalescence of a High-Concentration MAb

March 2010

Understanding the Basics of Peptide and Protein Production

Extended version from March supplement

The Business of Biotechnology

Growing the Future

February 2010

Focus On

Biopharmaceutical Information Infrastructure 2.0

Special Report

Special Report: The Time Has Come for Automation in Bioprocessing

CMC Forum

The Roles of Bioactivity Assays in Lot Release and Stability Testing

June 2009

Special Report

Impact of Scale on CoG savings

April 2009

Technical

E. coli Secretion Technologies Enable Production of High Yields of Active Human Antibody Fragments

June 2008

References

A Review of Therapeutic Protein Expression by Mammalian Cells

Special Online Feature

Successful Microbial

1 | 2 | NEXT PAGE»

Best of GE Healthcare - WEBINAR - Platform Approaches for the Purification of Antibody Fragments

Please join us for a free webinar discussing the purification challenges associated with antibody fragment purification and new solutions for a platform approach.

Wednesday 9 May 2012

We will present:

• A platform approach for purification of antibody fragments (Fabs)
• New chromatography media (resins) developed for industrial-scale capture of Fabs
• A complete purification process for a Fab developed using high-throughput tools

Speaker:
Gustav Rodrigo
Senior Scientist, R&D
GE Healthcare Life Sciences

Editors' Blog

How Cost-Effective Are US Cancer Prevention Services?

Dutch Public Health Service as Successful as U.S Private Services, but With Less Screening

Strategies for Rapid Production of Therapeutic Proteins in Mammalian Cells

Fed-Batch Cell Culture Process Optimization

Therapies of Tomorrow Require More Than Factories from the Past

Upstream Single-Use Bioprocessing Systems

New Plant Expression Systems Drive Vaccine Innovation and Opportunity

An Industry Perspective on Quality By Design

Current Issue